198 related articles for article (PubMed ID: 25364244)
1. Development of a lauric acid/albumin hybrid iron oxide nanoparticle system with improved biocompatibility.
Zaloga J; Janko C; Nowak J; Matuszak J; Knaup S; Eberbeck D; Tietze R; Unterweger H; Friedrich RP; Duerr S; Heimke-Brinck R; Baum E; Cicha I; Dörje F; Odenbach S; Lyer S; Lee G; Alexiou C
Int J Nanomedicine; 2014; 9():4847-66. PubMed ID: 25364244
[TBL] [Abstract][Full Text] [Related]
2. Studies on the adsorption and desorption of mitoxantrone to lauric acid/albumin coated iron oxide nanoparticles.
Zaloga J; Feoktystov A; Garamus VM; Karawacka W; Ioffe A; Brückel T; Tietze R; Alexiou C; Lyer S
Colloids Surf B Biointerfaces; 2018 Jan; 161():18-26. PubMed ID: 29035747
[TBL] [Abstract][Full Text] [Related]
3. Tangential Flow Ultrafiltration Allows Purification and Concentration of Lauric Acid-/Albumin-Coated Particles for Improved Magnetic Treatment.
Zaloga J; Stapf M; Nowak J; Pöttler M; Friedrich RP; Tietze R; Lyer S; Lee G; Odenbach S; Hilger I; Alexiou C
Int J Mol Sci; 2015 Aug; 16(8):19291-307. PubMed ID: 26287178
[TBL] [Abstract][Full Text] [Related]
4. Different storage conditions influence biocompatibility and physicochemical properties of iron oxide nanoparticles.
Zaloga J; Janko C; Agarwal R; Nowak J; Müller R; Boccaccini AR; Lee G; Odenbach S; Lyer S; Alexiou C
Int J Mol Sci; 2015 Apr; 16(5):9368-84. PubMed ID: 25918940
[TBL] [Abstract][Full Text] [Related]
5. Selection of potential iron oxide nanoparticles for breast cancer treatment based on in vitro cytotoxicity and cellular uptake.
Poller JM; Zaloga J; Schreiber E; Unterweger H; Janko C; Radon P; Eberbeck D; Trahms L; Alexiou C; Friedrich RP
Int J Nanomedicine; 2017; 12():3207-3220. PubMed ID: 28458541
[TBL] [Abstract][Full Text] [Related]
6. Pharmaceutical formulation of HSA hybrid coated iron oxide nanoparticles for magnetic drug targeting.
Zaloga J; Pöttler M; Leitinger G; Friedrich RP; Almer G; Lyer S; Baum E; Tietze R; Heimke-Brinck R; Mangge H; Dörje F; Lee G; Alexiou C
Eur J Pharm Biopharm; 2016 Apr; 101():152-62. PubMed ID: 26854862
[TBL] [Abstract][Full Text] [Related]
7. Development and characterization of magnetic iron oxide nanoparticles with a cisplatin-bearing polymer coating for targeted drug delivery.
Unterweger H; Tietze R; Janko C; Zaloga J; Lyer S; Dürr S; Taccardi N; Goudouri OM; Hoppe A; Eberbeck D; Schubert DW; Boccaccini AR; Alexiou C
Int J Nanomedicine; 2014; 9():3659-76. PubMed ID: 25120363
[TBL] [Abstract][Full Text] [Related]
8. Mitoxantrone-loaded superparamagnetic iron oxide nanoparticles as drug carriers for cancer therapy: Uptake and toxicity in primary human tubular epithelial cells.
Cicha I; Scheffler L; Ebenau A; Lyer S; Alexiou C; Goppelt-Struebe M
Nanotoxicology; 2016; 10(5):557-66. PubMed ID: 26468004
[TBL] [Abstract][Full Text] [Related]
9. Hypericin-bearing magnetic iron oxide nanoparticles for selective drug delivery in photodynamic therapy.
Unterweger H; Subatzus D; Tietze R; Janko C; Poettler M; Stiegelschmitt A; Schuster M; Maake C; Boccaccini AR; Alexiou C
Int J Nanomedicine; 2015; 10():6985-96. PubMed ID: 26648714
[TBL] [Abstract][Full Text] [Related]
10. Biocompatible superparamagnetic core-shell nanoparticles for potential use in hyperthermia-enabled drug release and as an enhanced contrast agent.
Patil-Sen Y; Torino E; De Sarno F; Ponsiglione AM; Chhabria V; Ahmed W; Mercer T
Nanotechnology; 2020 Sep; 31(37):375102. PubMed ID: 32392545
[TBL] [Abstract][Full Text] [Related]
11. The Impact of Serum Proteins and Surface Chemistry on Magnetic Nanoparticle Colloidal Stability and Cellular Uptake in Breast Cancer Cells.
Mekseriwattana W; Srisuk S; Kriangsaksri R; Niamsiri N; Prapainop K
AAPS PharmSciTech; 2019 Jan; 20(2):55. PubMed ID: 30618013
[TBL] [Abstract][Full Text] [Related]
12. Preparation of magnetic albumin nanoparticles via a simple and one-pot desolvation and co-precipitation method for medical and pharmaceutical applications.
Nosrati H; Salehiabar M; Manjili HK; Danafar H; Davaran S
Int J Biol Macromol; 2018 Mar; 108():909-915. PubMed ID: 29101048
[TBL] [Abstract][Full Text] [Related]
13. In vitro evaluation of actively targetable superparamagnetic nanoparticles to the folate receptor positive cancer cells.
Nasiri R; Hamzehalipour Almaki J; Idris AB; Abdul Majid FA; Nasiri M; Salouti M; Irfan M; Amini N; Marvibaigi M
Mater Sci Eng C Mater Biol Appl; 2016 Dec; 69():1147-58. PubMed ID: 27612812
[TBL] [Abstract][Full Text] [Related]
14. Bio-identity and fate of albumin-coated SPIONs evaluated in cells and by the C. elegans model.
Yu SM; Gonzalez-Moragas L; Milla M; Kolovou A; Santarella-Mellwig R; Schwab Y; Laromaine A; Roig A
Acta Biomater; 2016 Oct; 43():348-357. PubMed ID: 27427227
[TBL] [Abstract][Full Text] [Related]
15. Flow cytometry for intracellular SPION quantification: specificity and sensitivity in comparison with spectroscopic methods.
Friedrich RP; Janko C; Poettler M; Tripal P; Zaloga J; Cicha I; Dürr S; Nowak J; Odenbach S; Slabu I; Liebl M; Trahms L; Stapf M; Hilger I; Lyer S; Alexiou C
Int J Nanomedicine; 2015; 10():4185-201. PubMed ID: 26170658
[TBL] [Abstract][Full Text] [Related]
16. Bovine Serum Albumin (BSA) coated iron oxide magnetic nanoparticles as biocompatible carriers for curcumin-anticancer drug.
Nosrati H; Sefidi N; Sharafi A; Danafar H; Kheiri Manjili H
Bioorg Chem; 2018 Feb; 76():501-509. PubMed ID: 29310081
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and Characterization of Tissue Plasminogen Activator-Functionalized Superparamagnetic Iron Oxide Nanoparticles for Targeted Fibrin Clot Dissolution.
Heid S; Unterweger H; Tietze R; Friedrich RP; Weigel B; Cicha I; Eberbeck D; Boccaccini AR; Alexiou C; Lyer S
Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28837060
[TBL] [Abstract][Full Text] [Related]
18. Cellular effects of paclitaxel-loaded iron oxide nanoparticles on breast cancer using different 2D and 3D cell culture models.
Lugert S; Unterweger H; Mühlberger M; Janko C; Draack S; Ludwig F; Eberbeck D; Alexiou C; Friedrich RP
Int J Nanomedicine; 2019; 14():161-180. PubMed ID: 30613144
[TBL] [Abstract][Full Text] [Related]
19. Brain and bone cancer targeting by a ferrofluid composed of superparamagnetic iron-oxide/silica/carbon nanoparticles (earthicles).
Wu VM; Huynh E; Tang S; Uskoković V
Acta Biomater; 2019 Apr; 88():422-447. PubMed ID: 30711662
[TBL] [Abstract][Full Text] [Related]
20. Auto-degradable and biocompatible superparamagnetic iron oxide nanoparticles/polypeptides colloidal polyion complexes with high density of magnetic material.
Wang B; Sandre O; Wang K; Shi H; Xiong K; Huang YB; Wu T; Yan M; Courtois J
Mater Sci Eng C Mater Biol Appl; 2019 Nov; 104():109920. PubMed ID: 31500039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
